GDF15 and hydrops fetalis: Results from the RELAX-AHF study showed that higher levels of GDF-15 at baseline and larger increases at day 2 and day 14 were associated with significantly increased risks of the combined endpoint of 60-day HF rehospitalizations or CV death (74).